Nisa Investment Advisors
ATNM icon

Nisa Investment Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Nisa Investment Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328 Sell
330
-628
-66% -$747 ﹤0.01% 2917
2025
Q4 		$1.3K Hold
958
– – ﹤0.01% 2674
2025
Q3 		$1.53K Hold
958
– – ﹤0.01% 2669
2025
Q2 		$1.34K Sell
958
-402
-30% -$602 ﹤0.01% 2687
2025
Q1 		$2.19K Buy
1,360
+22
+2% +$28 ﹤0.01% 2447
2024
Q4 		$1.69K Buy
1,338
+1,106
+477% +$1.72K ﹤0.01% 2544
2024
Q3 		$436 Buy
232
+181
+355% +$715 ﹤0.01% 2741
2024
Q2 		$377 Buy
+51
New +$420 ﹤0.01% 2740
2023
Q4 		– Sell
-32
Closed -$189 – 2646
2023
Q3 		$189 Buy
+32
New +$213 ﹤0.01% 2675

Other funds holding ATNM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nisa Investment Advisors's ATNM Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Actinium Pharmaceuticals (ATNM) stake by 66% in Q1 2026, selling an estimated $747 and leaving 330 shares worth $328. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Nisa Investment Advisors first reported a position in ATNM in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.19K in Q1 2025. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.

  • Nisa Investment Advisors held 330 shares of Actinium Pharmaceuticals worth $328 as of Q1 2026.
  • Nisa Investment Advisors sold 628 Actinium Pharmaceuticals shares in Q1 2026, an estimated $747.
  • Actinium Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2917 holding.
  • Nisa Investment Advisors first reported a position in Actinium Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Actinium Pharmaceuticals position peaked at $2.19K in Q1 2025.
  • 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.